EnBio Holdings, Inc announced that it will issue 1,500,000 common shares at a price of ¥704 per share for gross proceeds of ¥1,056,000,000 on April 21, 2023. The transaction will includes participation from returning investor CRE, Inc. for 34.17% stake, currently owns 19.29% stake in the company. The company will issue shares through third-party allotment.

The transaction has been approved in the board of directors meeting. The transaction is expected to close on May 10, 2023. The company will pay ¥5,000,000 for document preparation costs, attorney fees, and registration costs related to transaction.